• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cellular and molecular characterization of human cardiac stem cells reveals key features essential for their function and safety.人类心脏干细胞的细胞和分子特征揭示了其功能和安全性所必需的关键特性。
Stem Cells Dev. 2015 Jun 15;24(12):1390-404. doi: 10.1089/scd.2014.0222.
2
Establishment of isolation and expansion protocols for human cardiac C-kit-positive progenitor cells for stem cell therapy.建立用于干细胞治疗的人类心脏C-试剂盒阳性祖细胞的分离和扩增方案。
Transplant Proc. 2013 Jan-Feb;45(1):420-6. doi: 10.1016/j.transproceed.2012.08.017.
3
Characterization of long-term cultured c-kit+ cardiac stem cells derived from adult rat hearts.成年大鼠心脏源性 c-kit+ 心脏干细胞的长期培养特性研究。
Stem Cells Dev. 2010 Jan;19(1):105-16. doi: 10.1089/scd.2009.0041.
4
Inhibition of Oct 3/4 mitigates the cardiac progenitor-derived myocardial repair in infarcted myocardium.抑制八聚体转录因子3/4可减轻梗死心肌中源自心脏祖细胞的心肌修复。
Stem Cell Res Ther. 2015 Dec 24;6:259. doi: 10.1186/s13287-015-0252-5.
5
Endogenous cardiac stem cells.内源性心脏干细胞
Prog Cardiovasc Dis. 2007 Jul-Aug;50(1):31-48. doi: 10.1016/j.pcad.2007.03.005.
6
Patient characteristics and cell source determine the number of isolated human cardiac progenitor cells.患者特征和细胞来源决定了分离的人心脏祖细胞的数量。
Circulation. 2009 Dec 22;120(25):2559-66. doi: 10.1161/CIRCULATIONAHA.109.849588. Epub 2009 Dec 7.
7
Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway.血管内皮生长因子通过 PI3K/Akt 通路促进心脏干细胞迁移。
Exp Cell Res. 2009 Dec 10;315(20):3521-31. doi: 10.1016/j.yexcr.2009.09.026. Epub 2009 Oct 2.
8
Cardiac Adipose-Derived Stem Cells Exhibit High Differentiation Potential to Cardiovascular Cells in C57BL/6 Mice.心脏脂肪来源干细胞在C57BL/6小鼠中对心血管细胞表现出高分化潜能。
Stem Cells Transl Med. 2016 Feb;5(2):141-51. doi: 10.5966/sctm.2015-0083. Epub 2015 Dec 18.
9
Resident human cardiac stem cells: role in cardiac cellular homeostasis and potential for myocardial regeneration.人类心脏驻留干细胞:在心脏细胞内环境稳定中的作用及心肌再生潜力
Nat Clin Pract Cardiovasc Med. 2006 Mar;3 Suppl 1:S8-13. doi: 10.1038/ncpcardio0409.
10
An in vitro model for the assessment of stem cell fate following implantation within the infarct microenvironment identifies ISL-1 expression as the strongest predictor of c-Kit(+) cardiac progenitor cells' therapeutic potential.一种用于评估干细胞在梗死微环境中植入后命运的体外模型确定,ISL-1表达是c-Kit(+)心脏祖细胞治疗潜力的最强预测指标。
J Mol Cell Cardiol. 2015 Nov;88:91-100. doi: 10.1016/j.yjmcc.2015.09.007. Epub 2015 Sep 21.

引用本文的文献

1
Establishment of A Three-Dimensional Culture Condition for The U266 Cell Line Based on Peripheral Blood Plasma-Derived Fibrin Gels.基于外周血血浆来源纤维蛋白凝胶建立U266细胞系的三维培养条件
Cell J. 2023 Apr 1;25(4):229-237. doi: 10.22074/cellj.2023.562849.1138.
2
Effect of intravenous cell therapy in rats with old myocardial infarction.静脉细胞治疗对陈旧性心肌梗死大鼠的影响。
Mol Cell Biochem. 2022 Feb;477(2):431-444. doi: 10.1007/s11010-021-04283-2. Epub 2021 Nov 16.
3
A critical appraisal of humanized alternatives to fetal bovine serum for clinical applications of umbilical cord derived mesenchymal stromal cells.对人源替代物替代胎牛血清用于脐带间充质干细胞临床应用的批判性评价。
Biotechnol Lett. 2021 Oct;43(10):2067-2083. doi: 10.1007/s10529-021-03180-4. Epub 2021 Sep 9.
4
Prediction of putative small molecules for manipulation of enriched signalling pathways in hESC-derived early cardiovascular progenitors by bioinformatics analysis.通过生物信息学分析预测用于调控人胚胎干细胞来源的早期心血管祖细胞中富集信号通路的潜在小分子。
IET Syst Biol. 2019 Apr;13(2):77-83. doi: 10.1049/iet-syb.2018.5037.
5
After the storm: an objective appraisal of the efficacy of c-kit+ cardiac progenitor cells in preclinical models of heart disease.风暴过后:对 c-kit+ 心脏祖细胞在心脏病临床前模型中的疗效进行客观评估。
Can J Physiol Pharmacol. 2021 Feb;99(2):129-139. doi: 10.1139/cjpp-2020-0406. Epub 2020 Sep 16.
6
A Cell-Free SDKP-Conjugated Self-Assembling Peptide Hydrogel Sufficient for Improvement of Myocardial Infarction.一种无细胞的 SDKP 缀合自组装肽水凝胶,足以改善心肌梗死。
Biomolecules. 2020 Jan 30;10(2):205. doi: 10.3390/biom10020205.
7
Expansion of Human Pluripotent Stem Cell-derived Early Cardiovascular Progenitor Cells by a Cocktail of Signaling Factors.通过信号因子鸡尾酒扩大人类多能干细胞来源的早期心血管祖细胞。
Sci Rep. 2019 Nov 5;9(1):16006. doi: 10.1038/s41598-019-52516-8.
8
Establishment of A Protocol for In Vitro Culture of Cardiogenic Mesodermal Cells Derived from Human Embryonic Stem Cells.建立一种用于人胚胎干细胞来源的心脏中胚层细胞体外培养的方案。
Cell J. 2019 Jan;20(4):496-504. doi: 10.22074/cellj.2019.5661. Epub 2018 Dec 12.
9
Exosomes Secreted by Normoxic and Hypoxic Cardiosphere-derived Cells Have Anti-apoptotic Effect.常氧和低氧条件下心脏球源细胞分泌的外泌体具有抗凋亡作用。
Iran J Pharm Res. 2018 Winter;17(1):377-385.
10
Transient Activation of Reprogramming Transcription Factors Using Protein Transduction Facilitates Conversion of Human Fibroblasts Toward Cardiomyocyte-Like Cells.利用蛋白质转导短暂激活重编程转录因子有助于将人成纤维细胞转化为类心肌细胞。
Mol Biotechnol. 2017 Jun;59(6):207-220. doi: 10.1007/s12033-017-0007-x.

本文引用的文献

1
Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells.在急性心肌梗死猪模型中用人诱导多能干细胞衍生的心血管细胞进行心脏修复。
Cell Stem Cell. 2014 Dec 4;15(6):750-61. doi: 10.1016/j.stem.2014.11.009.
2
The cardiac stem cell compartment is indispensable for myocardial cell homeostasis, repair and regeneration in the adult.心脏干细胞区室对于成体心肌细胞的稳态、修复和再生不可或缺。
Stem Cell Res. 2014 Nov;13(3 Pt B):615-30. doi: 10.1016/j.scr.2014.04.008. Epub 2014 Apr 29.
3
Endogenous cardiac stem cells for the treatment of heart failure.用于治疗心力衰竭的内源性心脏干细胞
Stem Cells Cloning. 2013 Mar 25;6:1-12. doi: 10.2147/SCCAA.S29221.
4
Dissecting the molecular relationship among various cardiogenic progenitor cells.解析各种心源性祖细胞之间的分子关系。
Circ Res. 2013 Apr 26;112(9):1253-62. doi: 10.1161/CIRCRESAHA.112.300779. Epub 2013 Mar 5.
5
Cardiac stem cells: A promising treatment option for heart failure.心脏干细胞:心力衰竭的一种有前景的治疗选择。
Exp Ther Med. 2013 Feb;5(2):379-383. doi: 10.3892/etm.2012.854. Epub 2012 Dec 5.
6
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.1990年和2010年20个年龄组中235种死因的全球和区域死亡率:全球疾病负担研究2010的系统分析
Lancet. 2012 Dec 15;380(9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0.
7
Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations.按国家/地区和年龄划分的缺血性心脏病死亡率:世界卫生组织和联合国的统计数据。
Int J Cardiol. 2013 Sep 30;168(2):934-45. doi: 10.1016/j.ijcard.2012.10.046. Epub 2012 Dec 4.
8
'Shovel-Ready' applications of stem cell advances for pediatric heart disease.用于儿科心脏病的干细胞进展的“即插即用”应用。
Curr Opin Pediatr. 2012 Oct;24(5):577-83. doi: 10.1097/MOP.0b013e328357a4cf.
9
Optimizing cardiac repair and regeneration through activation of the endogenous cardiac stem cell compartment.通过激活内源性心脏干细胞隔室来优化心脏修复和再生。
J Cardiovasc Transl Res. 2012 Oct;5(5):667-77. doi: 10.1007/s12265-012-9384-5. Epub 2012 Jun 12.
10
Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells.不同干细胞类型和亚群的直接比较显示,心球源性细胞具有更好的旁分泌效力和心肌修复效果。
J Am Coll Cardiol. 2012 Mar 6;59(10):942-53. doi: 10.1016/j.jacc.2011.11.029.

人类心脏干细胞的细胞和分子特征揭示了其功能和安全性所必需的关键特性。

Cellular and molecular characterization of human cardiac stem cells reveals key features essential for their function and safety.

作者信息

Vahdat Sadaf, Mousavi Seyed Ahmad, Omrani Gholamreza, Gholampour Maziar, Sotoodehnejadnematalahi Fattah, Ghazizadeh Zaniar, Gharechahi Javad, Baharvand Hossein, Salekdeh Ghasem Hosseini, Aghdami Nasser

机构信息

1Department of Stem Cells and Developmental Biology at Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.

2Department of Biotechnology, College of Science, University of Tehran, Tehran, Iran.

出版信息

Stem Cells Dev. 2015 Jun 15;24(12):1390-404. doi: 10.1089/scd.2014.0222.

DOI:10.1089/scd.2014.0222
PMID:25867933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4484714/
Abstract

Cell therapy of heart diseases is emerging as one of the most promising known treatments in recent years. Transplantation of cardiac stem cells (CSCs) may be one of the best strategies to cure adult or pediatric heart diseases. As these patient-derived stem cells need to be isolated from small heart biopsies, it is important to select the best isolation method and CSC subpopulation with the best cardiogenic functionality. We employed three different protocols including c-KIT(+) cell sorting, clonogenic expansion, and explants culture to isolate c-KIT(+) cells, clonogenic expansion-derived cells (CEDCs), and cardiosphere-derived cells (CDCs), respectively. Evaluation of isolated CSC characteristics in vitro and after rat myocardial infarction (MI) model transplantation revealed that although c-KIT(+) and CDCs had higher MI regenerative potential, CEDCs had more commitment into cardiomyocytes and needed lower passages that were essential to reach a definite cell count. Furthermore, genome-wide expression analysis showed that subsequent passages caused changes in characteristics of cells, downregulation of cell cycle-related genes, and upregulation of differentiation and carcinogenic genes, which might lead to senescence, commitment, and possible tumorigenicity of the cells. Because of different properties of CSC subpopulations, we suggest that appropriate CSCs subpopulation should be chosen based on their experimental or clinical use.

摘要

近年来,心脏病的细胞疗法正成为最具前景的已知治疗方法之一。心脏干细胞(CSCs)移植可能是治疗成人或儿童心脏病的最佳策略之一。由于这些源自患者的干细胞需要从小的心脏活检组织中分离出来,因此选择最佳的分离方法和具有最佳心脏生成功能的CSC亚群非常重要。我们采用了三种不同的方案,包括c-KIT(+)细胞分选、克隆扩增和外植体培养,分别分离c-KIT(+)细胞、克隆扩增衍生细胞(CEDCs)和心球衍生细胞(CDCs)。对分离出的CSC特性进行体外评估以及在大鼠心肌梗死(MI)模型移植后的评估表明,虽然c-KIT(+)细胞和CDCs具有更高的MI再生潜力,但CEDCs向心肌细胞的分化能力更强,且达到确定细胞数量所需的传代次数更低。此外,全基因组表达分析表明,后续传代会导致细胞特性发生变化,细胞周期相关基因下调,分化和致癌基因上调,这可能导致细胞衰老、分化以及可能的致瘤性。由于CSC亚群具有不同的特性,我们建议应根据其实验或临床用途选择合适的CSC亚群。